Nexalin Technology Inc./$NXL
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Nexalin Technology Inc.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
Ticker
$NXL
Sector
Primary listing
Employees
8
Headquarters
Website
NXL Metrics
BasicAdvanced
$8.1m
-
-$0.46
3.83
-
Price and volume
Market cap
$8.1m
Beta
3.83
52-week high
$2.00
52-week low
$0.31
Average daily volume
979k
Financial strength
Current ratio
4.07
Quick ratio
3.404
Profitability
EBITDA (TTM)
-8.472
Gross margin (TTM)
81.99%
Net profit margin (TTM)
-3,022.94%
Operating margin (TTM)
-3,084.03%
Revenue per employee (TTM)
$30,000
Management effectiveness
Return on assets (TTM)
-161.10%
Return on equity (TTM)
-319.69%
Valuation
Price to revenue (TTM)
25.7
Price to book
2.8
Price to tangible book (TTM)
3.2
Price to free cash flow (TTM)
-1.312
Free cash flow yield (TTM)
-76.20%
Free cash flow per share (TTM)
-0.299
Growth
Revenue change (TTM)
110.26%
Earnings per share change (TTM)
-42.27%
3-year revenue growth (CAGR)
-35.53%
3-year earnings per share growth (CAGR)
11.60%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs